Role of bone-anabolic agents in the treatment of breast cancer bone metastases

Breast Cancer Research : BCR
Attaya Suvannasankha, John M Chirgwin

Abstract

Skeletal metastases are an incurable complication afflicting the majority of patients who die from advanced breast cancer. They are most often osteolytic, characterized by net bone destruction and suppressed new bone formation. Life expectancy from first diagnosis of breast cancer bone metastases is several years, during which time skeletal-related events - including pain, fracture, hypercalcemia, and spinal cord compression - significantly degrade quality of life. The bone marrow niche can also confer hormonal and chemo-resistance. Most treatments for skeletal metastases target bone-destroying osteoclasts and are palliative. Recent results from the Breast cancer trials of Oral Everolimus-2 trial suggest that agents such as the mammalian target of rapamycin inhibitor everolimus may have efficacy against breast cancer bone metastases in part via stimulating osteoblasts as well as by inhibiting tumor growth. Selective estrogen receptor modulators similarly inhibit growth of estrogen receptor-positive breast cancers while having positive effects on the skeleton. This review discusses the future role of bone-anabolic agents for the specific treatment of osteolytic breast cancer metastases. Agents with both anti-tumor and bone-anabo...Continue Reading

References

Feb 14, 1998·British Journal of Cancer·R E ColemanR D Rubens
Jul 20, 2002·Current Molecular Medicine·Gabriela Motyckova, David E Fisher
Sep 23, 2003·Cell Death and Differentiation·H GlantschnigA A Reszka
Aug 23, 2006·European Journal of Haematology·Ulrike HeiderOrhan Sezer
Nov 18, 2006·The Oncologist·Theresa A Guise
Sep 19, 2007·British Journal of Cancer·N Voorzanger-RousselotP Garnero
Dec 7, 2007·Cancer Biology & Therapy·Mojtaba AkhtariPrem Seth
Oct 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Akihiro YanoLen Neckers
May 13, 2009·Experimental Cell Research·Roman KrawetzJohn Matyas
Jul 21, 2009·Molecular and Cellular Endocrinology·Sandra CasimiroJohn Chirgwin
Oct 24, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Peyman HadjiMatthias Kalder
Mar 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sonia ValletNoopur Raje
Jun 10, 2010·Journal of Cellular Physiology·Gaetano Leto
Jun 10, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Andrew D ChantryPeter Croucher
Sep 17, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marci D JonesJane B Lian
Dec 24, 2010·Breast Cancer Research : BCR·Yu-Chi ChenAndrea M Mastro
Jul 12, 2011·Journal of the National Cancer Institute·Eitan AmirAlberto Ocaña
Nov 3, 2011·Anti-cancer Agents in Medicinal Chemistry·John M Chirgwin
Dec 6, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Sonia Vallet, Noopur Raje
Dec 14, 2011·The New England Journal of Medicine·José BaselgaGabriel N Hortobagyi
Mar 1, 2012·Cancer Treatment Reviews·Nigel Bundred
May 1, 2012·Nature Reviews. Drug Discovery·David L LaceyRoger Dansey
May 2, 2012·The Journal of Biological Chemistry·Maria TarragonaRoger R Gomis
Jun 5, 2012·Cell Adhesion & Migration·Koichi Matsuo, Natsuko Otaki
Jun 23, 2012·Endocrine Reviews·Hua Zhu KeMichael S Ominsky
Sep 4, 2012·Bone·Charles A O'BrienHiroshi Takayanagi
Nov 7, 2012·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Simon WöhrleDiana Graus Porta
Apr 25, 2013·Nature Reviews. Cancer·Lalage M Wakefield, Caroline S Hill
Jul 11, 2013·Critical Reviews in Oncology/hematology·Peyman HadjiMichael Gnant
Aug 9, 2013·Journal of Bone and Mineral Metabolism·Jan J Stepan
Jan 1, 2012·BoneKEy Reports·Jeroen T BuijsTheresa A Guise
Oct 8, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jinlu DaiEvan T Keller

❮ Previous
Next ❯

Citations

Oct 21, 2016·Journal of Bone Oncology·Penelope D Ottewell
Oct 21, 2016·Journal of Bone Oncology·Robert Coleman
Oct 16, 2015·BMC Cancer·Valeria SimoneFranco Silvestris
Jul 25, 2017·Endocrine-related Cancer·Catherine ZabkiewiczLin Ye
Feb 29, 2016·Calcified Tissue International·Gengyang ShenXiaobing Jiang
May 15, 2020·Clinical Nuclear Medicine·Jiali TangFuqiang Shao
Sep 29, 2018·International Journal of Molecular Sciences·Hannah K BrownIngunn Holen
Apr 2, 2020·Frontiers in Oncology·Marie-Therese HaiderHanna Taipaleenmäki

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies

Clinical Trials Mentioned

NCT01674140
NCT00747123

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Clinical Advances in Hematology & Oncology : H&O
Rebecca Aft
Best Practice & Research. Clinical Haematology
Flavia R Esteve, G David Roodman
Cancer Control : Journal of the Moffitt Cancer Center
L S LoftusG H Sokol
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society
Sonia Vallet, Noopur Raje
© 2022 Meta ULC. All rights reserved